Drugs / Isolated cadaveric islet cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05480657 | Sep 2022 → Aug 2024 | type 1 diabetes mellitus | Eledon Pharmaceuticals | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Isolated cadaveric islet cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05480657 ↗ |
| Modality | Cell therapy | “transplanted islet cells” NCT05480657 ↗ |
| Route | Other | “Infusion of human cadaveric islet cells into the portal vein” NCT05480657 ↗ |